Cargando…
Outcome of Nivolumab-Induced Vogt–Koyanagi–Harada Disease-Like Uveitis in a Patient Managed without Intravenous Methylprednisolone Therapy
BACKGROUND: In recent years, immune checkpoint inhibitors (ICI) have been often used for several types of cancers. Immune-related adverse events (irAEs) are autoimmune responses caused by ICI. Among the different types of irAEs, uveitis is common in ophthalmology. Moreover, there are reports on Vogt...
Autores principales: | Nagai, Ryoji, Yamamoto, Akinari, Yoshida, Akiko, Mikawa, Akiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931485/ https://www.ncbi.nlm.nih.gov/pubmed/36818144 http://dx.doi.org/10.1155/2023/9565205 |
Ejemplares similares
-
A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy
por: Minami, Keisuke, et al.
Publicado: (2021) -
Commentary: Appraisal of histopathological correlations in Vogt-Koyanagi-Harada uveitis
por: Murugan, Sivaraman Bala
Publicado: (2019) -
Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis
por: Park, Jong G., et al.
Publicado: (2020) -
Tuberculous Posterior Sclero-Uveitis with Features of Vogt-Koyanagi-Harada Uveitis: An Unusual Case
por: Kalogeropoulos, Dimitrios, et al.
Publicado: (2017) -
Vogt–Koyanagi–Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report
por: Kikuchi, Ryo, et al.
Publicado: (2020)